Literature DB >> 26670675

The microbiome of diabetic foot osteomyelitis.

S A V van Asten1,2, J La Fontaine3, E J G Peters4, K Bhavan5, P J Kim6, L A Lavery3.   

Abstract

The purpose of this investigation was to evaluate the diversity of bacteria in diabetic foot osteomyelitis using a 16S rRNA sequencing approach and to compare the results with conventional culture techniques. In this prospective observational study, we obtained 34 bone samples from patients admitted to our hospital with a moderate-severe diabetic foot infection. We analysed the distribution of the 16S rRNA gene sequences in the bone samples, using an Illumina MiSeq Personal Sequencer. We compared the genera that were detected with the cultured pathogens in the bone samples with conventional techniques. In the 23 samples that had positive results with both techniques, Staphylococcus, Corynebacterium, Streptococcus and Propionibacterium spp. were detected in 20, 18, 13 and 11 samples, respectively. Significantly more anaerobes were detected with 16S rRNA sequencing compared to conventional techniques (86.9 % vs. 23.1 %, p = 0.001) and more Gram-positive bacilli were present (78.3 % vs. 3.8 %, p < 0.001). Staphylococcus spp. were identified in all of the sequenced bone samples that were negative with conventional techniques. Mixed genera were present in 83.3 % (5 of 6) of the negative samples. Anaerobic and fastidious organisms may play a more significant role in osteomyelitis than previously reported. Further studies with larger populations are needed in order to fully understand the clinical importance of the microbial diversity of diabetic foot osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26670675      PMCID: PMC4724363          DOI: 10.1007/s10096-015-2544-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


Introduction

Diabetic foot osteomyelitis (DFO) develops in approximately 44–68 % of patients with diabetes mellitus admitted to the hospital with a diabetic foot infection (DFI) [1] and is the leading cause of amputation among such patients [2]. The microbiologic spectrum of DFO seems to be similar to deep diabetic foot soft tissue infections [3] and primarily consists of Gram-positive bacteria, especially Staphylococcus aureus and beta haemolytic streptococci [4, 5]. Anaerobic pathogens are generally uncommon, with some studies reporting that only 3–14 % of infections involve anaerobes [6]. More recent studies indicate that 46–85 % of DFO are monomicrobial [7, 8]. However, conventional culture techniques focus on organisms easily cultured using traditional microbiological evaluations and are limited by the time required for organisms to grow [9]. The phenomenon that only a small percentage of microorganisms grow on agar plates has been known as the ‘great plate count anomaly’ since the early 20th century [10]. Little is known about the diversity of bacteria in DFO and the contribution of anaerobic and fastidious organisms to these infections [11]. This study aimed to better characterise the bacterial ecology of DFO using a modern 16S ribosomal ribonucleic acid (rRNA) gene sequencing approach.

Materials and methods

Patient population

We consecutively obtained 34 bone samples from patients admitted to our hospital with moderate–severe DFI according to the diabetic foot infection classification of the Infectious Diseases Society of America (IDSA) [12]. We included patients who were 21 years or older and had high suspicion of DFO based on their IDSA classification. Exclusion criteria included other infectious diseases, active, previously diagnosed DFO in the study foot, immunosuppressive therapy, organ and/or haematological malignancies, and end-stage renal disease requiring dialysis. We performed a percutaneous biopsy using a 16 gauge Jamshidi needle introduced at least 2 cm from the ulcer site [6] (n = 7) or we obtained intraoperative bone samples from the patients that required surgical debridement or amputation (n = 27). We sent the obtained bone samples to the laboratory for conventional culturing and histopathological tests. We used our hospital microbiology laboratory’s established protocol for anaerobic sampling and transport. The bone specimens were placed in sterile cups without any transport medium and processed within 1 h of collection. Laboratory technicians were kept unaware of the clinical data. We stored a part of the obtained samples promptly at −80 °C until the end of the study. Informed consent was obtained from all individual participants included in the study.

16S rRNA gene sequencing

After thawing, we recovered portions of the bone samples using sterile forceps. We extracted genomic DNA using the Roche High Pure PCR Template Preparation Kit (Roche Life Sciences, Indianapolis, IN, USA) with a modified lysis step. We lysed our samples by combining 25 mg of sample, 200 μL each of lysis buffer and binding buffer (kit buffers 1 and 2), 500 μL of zirconium oxide beads and a single 5-mm steel bead in a 200-μL screw-cap tube. We shook the tubes using a TissueLyser II (Qiagen, Inc., Valencia, CA, USA) for 5 min at 30 Hz. We continued the extraction using the manufacturer’s instructions. We used the Illumina MiSeq Personal Sequencer (Illumina, Inc., San Diego, CA, USA) in collaboration with PathoGenius Laboratories (PathoGenius, Lubbock, TX, USA) to assess the distribution of 16S rRNA gene sequences. We amplified the samples for sequencing using a forward and a reverse fusion primer. The forward primer was constructed with the (5′-3′) Illumina i5 adapter, an 8–10-bp barcode, a primer pad and the 28F primer. The reverse fusion primer was constructed with the (5′-3′) Illumina i7 adapter, an 8–10-bp barcode, a primer pad and the 519R primer. We used the HotStarTaq Plus Master Mix Kit (Qiagen, Inc., Valencia, CA, USA) for polymerase chain reaction (PCR) under the following conditions: 94 °C for 3 min; followed by 30 cycles of 94 °C for 30 s, 60 °C for 40 s and 72 °C for 1 min; and a final elongation step at 72 °C for 5 min. In preparation for 16S sequencing, we denoised the DNA to remove short sequences, singleton sequences and noisy reads [13]. With the bad reads removed, we performed chimera detection using the de novo method built into UCHIME [14] to aid in the removal of chimeric sequences [15]. We corrected the remaining sequences base by base to help remove noise from within each sequence. We quality checked and demultiplexed the denoised and chimera-checked reads generated during sequencing. We then clustered these sequences into operational taxonomic units (OTUs) using the UPARSE algorithm [16]. We ran the centroid sequence from each cluster against a database of high-quality sequences derived from the National Center for Biotechnology Information (NCBI) database, March 2015. We used an internally developed Python program that assigns taxonomic information to each sequence to analyse the output and write the final analysis files.

Statistical analysis

Analysis was performed using the SAS 9.4 statistical package. The data were presented as number of patients (%). Differences between both culture techniques were measured using the McNemar’s test. p-Values <0.05 were considered statistically significant.

Results

Of the 26 bone samples that grew pathogens with conventional culturing techniques, three did not sequence. The three samples that did not sequence grew Stenotrophomonas maltophilia (n = 1), S. aureus (n = 1) and Enterobacter cloacae (n = 1) with conventional culturing. All three samples were monomicrobial infections. Table 1 presents an overview of all the genera that were sequenced and occurred in at least 21.7 % (5 of 23) of the positive bone samples. The table includes the average contribution of each genus to the total bacterial population in those samples as represented as a percentage. Staphylococcus spp. were the predominant genus identified in the positive bone samples. Sequences of Staphylococcus spp. were detected in 20 of the 23 samples, with an average contribution of 28.6 % to the total bacterial population. The most prevalent populations of Gram-positive cocci identified after that were, in order, Corynebacterium (n = 18), Streptococcus (n = 13) and Propionibacterium spp. (n = 11). Facultative anaerobes included Actinomyces and Helcococcus spp. in 6 and 5 of the samples, respectively. Obligate anaerobes such as Peptoniphilus, Finegoldia, Anaerococcus, Clostridium, Porphyromonas and Prevotella were detected in 17, 15, 12, 9, 7 and 5 of the samples, respectively. Two of the positive samples were low coverage samples (sequence counts of 9 and 534, respectively). Both of these low coverage samples only had sequences that matched with Staphylococcus spp. and grew coagulase-negative staphylococci with conventional techniques.
Table 1

Bacterial genera identified with 16S ribosomal ribonucleic acid (rRNA) sequencing in 23 positive bone samples

Genera*SamplesAvg %SDMin–max %
No hit2215.626.10.03–87.1
Staphylococcus spp.2028.634.60.17–98.8
Corynebacterium spp.187.010.70.01–33.8
Peptoniphilus spp.172.33.10.01–11.7
Unknown Firmicutes 1613.119.50.02–55.6
Finegoldia spp.158.111.80.17–44.6
Unknown Clostridiales143.38.40.02–32.1
Streptococcus spp.1320.119.50.03–57.9
Anaerococcus spp.128.28.70.06–27.6
Propionibacterium spp.110.91.70.002–5.0
Clostridium spp.90.91.10.008–3.3
Unknown Dermabacteriae80.10.10.03–0.3
Unclassified Clostridiales81.11.60.008–3.9
Unknown Clostridia82.02.10.03–6.8
Porphyromonas spp.71.81.70.03–4.8
Unclassified Clostridia71.31.50.004–3.6
Unknown bacteria72.25.10.01–13.8
Actinomyces spp.61.01.80.003–4.7
Enterobacter spp.66.011.30.10–28.8
Prevotella spp.53.25.50.04–13.0
Helcococcus spp.51.21.50.05–3.8
Pseudomonas spp.520.842.83.90–52.6

*Genera sequenced that occurred in at least 21.7 % (5 of 23) of the positive bone samples. The genera are sorted by the number of bone samples in which they were detected

Avg % average percentage each genus contributed to its positive samples; SD standard deviation of the percentages; Min–max % range of the percentages; No hit sequence has no match with the sequences in the NCBI database

Bacterial genera identified with 16S ribosomal ribonucleic acid (rRNA) sequencing in 23 positive bone samples *Genera sequenced that occurred in at least 21.7 % (5 of 23) of the positive bone samples. The genera are sorted by the number of bone samples in which they were detected Avg % average percentage each genus contributed to its positive samples; SD standard deviation of the percentages; Min–max % range of the percentages; No hit sequence has no match with the sequences in the NCBI database Table 2 presents a comparison of the results of both culturing techniques. Only the genera that occurred in at least 21.7 % (5 of 23) of the positive bone samples with the sequencing method are reported. With 16S rRNA sequencing, we found significantly more anaerobic pathogens (86.9 % vs. 23.1 %, p = 0.001), significantly more Gram-positive bacilli (78.3 % vs. 3.8 %, p < 0.001) and more polymicrobial infections (91.3 % vs. 64.0 %, p = 0.125). Also, greater bacterial diversity was seen both in the Gram-positive cocci and the anaerobes.
Table 2

Bacterial genera in diabetic foot osteomyelitis (DFO) with the two culturing techniques

Conventional culture techniques16S rRNA sequencing*
PathogensOverall (%), total number of patients = 26PathogensOverall (%) total number of patients, = 23
Gram-positive cocci 20 (76.9) Gram-positive cocci 23 (100.0)
S. aureus, total13 (50.0) Staphylococcus spp.20 (86.9)
S. aureus resistant to methicillin3 (11.5) S. aureus resistant to methicillinNot tested
Coagulase-negative staphylococci11 (42.3)Coagulase-negative staphylococciNot tested
Streptococcus spp.6 (23.1) Streptococcus spp.13 (56.5)
Enterococcus spp.2 (7.7) Enterococcus spp.0
Unknown Dermabacteriae8 (34.8)
Gram-positive bacilli 1 (3.8) Gram-positive bacilli 18 (78.3)
Corynebacterium spp.1 (3.8) Corynebacterium spp.18 (78.3)
Gram-negative bacilli 13 (50.0) Gram-negative bacilli 10 (43.5)
P. aeruginosa 4 (15.4) Pseudomonas spp.5 (21.7)
S. maltophilia 1 (3.8) S. maltophilia 0
Proteus spp.1 (3.8) Proteus spp.0
Enterobacter spp.6 (26.1)
Anaerobes 6 (23.1) Anaerobes 20 (86.9)
Facultative anaerobes3 (11.5)Facultative anaerobes17 (73.9)
Propionibacterium spp.11 (47.8)
Actinomyces spp.6 (26.1)
Helcococcus spp.5 (21.7)
Obligate anaerobes3 (11.5)Obligate anaerobes20 (86.9)
Peptoniphilus spp.17 (73.9)
Finegoldia spp.15 (65.2)
Anaerococcus spp.12 (52.2)
Porphyromonas spp.7 (30.4)
Prevotella spp.5 (21.7)
Unknown Firmicutes 16 (69.6)
Unknown/unclassified Clostridia15 (65.2)
Unknown/unclassified Clostridiales22 (95.7)
Clostridium spp.9 (39.1)
Polymicrobial infections 16 (64.0) Polymicrobial infections 21 (91.3)
Unknown bacteria NA Unknown bacteria 7 (30.4)

*Genera sequenced that occurred in at least 21.7 % (5 of 23) of the positive bone samples. Data are number of patients (%)

Bacterial genera in diabetic foot osteomyelitis (DFO) with the two culturing techniques *Genera sequenced that occurred in at least 21.7 % (5 of 23) of the positive bone samples. Data are number of patients (%) No pathogens were identified in 8 out of the 34 bone samples (23.5 %) with conventional culture techniques. Two out of those eight negative samples did not sequence either. The genera that were sequenced in the remaining six and occurred in at least 33.3 % (2 of 6) of the samples are presented in Table 3. Staphylococcus spp. were detected in all of the negative samples, with an average contribution of 21.8 % to the total bacterial population. One of the negative samples was a very low coverage sample (sequence count 3); all three sequences matched with the Staphylococcus spp. sequence derived from the NCBI database. This was the only negative bone sample that had a single genus present.
Table 3

Bacterial genera identified with 16S rRNA sequencing in six negative bone samples

Genera*SamplesAvg %SDMin–max %
Staphylococcus spp.621.839.30.05–100.0
No hit449.940.85.07–97.9
Corynebacterium spp.33.81.61.99–5.0
Propionibacterium spp.35.99.50.35–16.8
Streptococcus spp.312.215.31.37–29.7
Anaerococcus spp34.45.61.12–10.9
Finegoldia spp.36.83.23.14–8.9
Peptoniphilus spp.31.91.41.02–3.5
Unknown Firmicutes 37.29.10.03–17.4
Enterobacter spp.30.20.20.02–0.5
Unknown Microbacteriaceae27.610.40.27–15.0
Unknown Enterobacter 20.40.50.02–0.7
Pseudomonas spp.218.426.00.04–36.8
Unknown bacteria20.40.30.20–0.7

*Genera sequenced that occurred in at least 33.3 % (2 of 6) of the negative bone samples. The genera are sorted by the number of bone samples in which they were detected

Avg % average percentage each genus contributed to its positive samples; SD standard deviation of the percentages; Min–max % range of the percentages; No hit sequence has no match with the sequences in the NCBI database

Bacterial genera identified with 16S rRNA sequencing in six negative bone samples *Genera sequenced that occurred in at least 33.3 % (2 of 6) of the negative bone samples. The genera are sorted by the number of bone samples in which they were detected Avg % average percentage each genus contributed to its positive samples; SD standard deviation of the percentages; Min–max % range of the percentages; No hit sequence has no match with the sequences in the NCBI database

Conclusions

The primary genus detected in the bone samples of the current study was the Staphylococcus spp., both with conventional culturing techniques and with 16S ribosomal ribonucleic acid (rRNA) gene sequencing. Not only was it detected in 89.6 % (26 of 29) of the sequenced samples, its average contribution to the total bacterial population was the highest of all the genera. This is not a surprising result, since nearly every study reported in the North American and European literature identifies Staphylococcus aureus as the most common pathogen cultured in diabetic foot osteomyelitis (DFO), followed by S. epidermidis [1]. The Corynebacterium spp. was the most prevalent population after Staphylococcus spp. However, the average contribution of this genus to the total bacterial population appears to be much lower. This fastidious organism has been associated with DFO in previous studies that used traditional culturing methods [17, 18]. In a recent study by Dowd et al. [11], the Corynebacterium spp. was even identified as the predominant genus in the individual ecologies of 40 diabetic foot ulcers using a similar sequencing approach. The Staphylococcus spp. was only detected in 13 of the 40 debridement samples. However, the pathogenic role of Corynebacterium spp. in infections is not well understood and the genus is usually considered a contaminant. Because DFO is not typically exposed to air, especially if peripheral arterial disease is present, anaerobes may play a bigger role than expected. As has been previously reported in studies using pyrosequencing to characterise bacterial diversity in chronic osteomyelitis of the jaw [19], osteomyelitis was not caused by a single pathogen but by diverse bacteria comprising both aerobic and anaerobic species, including unculturable bacteria with conventional culturing methods. Only 3 out of our 29 sequenced bone samples had a single genus of bacteria present, and all three of these samples had low sequence counts, so they may have been contaminants. Our results show that, by using a 16S rRNA sequencing technique, anaerobes were detected in 86.9 % of the positive bone samples (vs. 23.1 % with conventional techniques). The number of anaerobes seems to be largely dependent on the culturing method. In studies by Senneville et al. [6] and Ertugrul et al. [20], obligate anaerobes were identified in only 3 % and 5 % of patients, respectively, after optimising the culturing methods. All of the patients enrolled in the study were admitted to our hospital with moderate/severe Infectious Diseases Society of America (IDSA) infections that required antibiotics and surgery urgently per IDSA treatment guidelines. Therefore, a limitation of our study design is the high pre-test probability of osteomyelitis and the relatively small number of negative subjects. In addition, we did not have a ‘wash-out’ period with no antibiotic therapy before bone cultures were obtained. While this convention is discussed in the medical literature, there is no direct evidence that it affects the results of either culture technique. However, previous antibiotic therapy may have favoured the results of 16S rRNA sequencing, since pathogens did not need to be viable in order to be detected. The use of advanced biological molecular technology is of particular interest in DFO, wherein the chronicity of the infection and the adhesion of bacteria in a sessile phenotype may make it difficult to culture these pathogens [21]. The diversity of the bacterial population may contribute to the poor success rates of medical treatment of DFO [22-24]. Studies report prolonged treatment courses with antibiotics in non-surgical cases ranging from 42 to 90 days [25], up to even 40 weeks [26], as well as considerable variation in success (57–70 %) [25]. Culture-specific antibiotic treatment has been reported to provide a higher rate of treatment success compared to empiric therapy [7]. A better understanding of the bacterial diversity in DFO will provide new insights to redirect therapy and might improve clinical outcomes in the future [27].
  26 in total

Review 1.  A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot.

Authors:  E J G Peters; B A Lipsky; A R Berendt; J M Embil; L A Lavery; E Senneville; V Urbančič-Rovan; K Bakker; W J Jeffcoate
Journal:  Diabetes Metab Res Rev       Date:  2012-02       Impact factor: 4.876

Review 2.  The diabetic foot: the importance of biofilms and wound bed preparation.

Authors:  Stephen C Davis; Lisa Martinez; Robert Kirsner
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

3.  UPARSE: highly accurate OTU sequences from microbial amplicon reads.

Authors:  Robert C Edgar
Journal:  Nat Methods       Date:  2013-08-18       Impact factor: 28.547

4.  Analysis of the factors affecting the formation of the microbiome associated with chronic osteomyelitis of the jaw.

Authors:  A Goda; F Maruyama; Y Michi; I Nakagawa; K Harada
Journal:  Clin Microbiol Infect       Date:  2013-11-11       Impact factor: 8.067

5.  Oral antimicrobial therapy for diabetic foot osteomyelitis.

Authors:  John M Embil; Greg Rose; Elly Trepman; Mary Cheang M Math; Frank Duerksen; J Neil Simonsen; Lindsay E Nicolle
Journal:  Foot Ankle Int       Date:  2006-10       Impact factor: 2.827

6.  2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; Paul B Cornia; James C Pile; Edgar J G Peters; David G Armstrong; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Michael S Pinzur; Eric Senneville
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

7.  Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study.

Authors:  Eric Senneville; Audrey Lombart; Eric Beltrand; Michel Valette; Laurence Legout; Marie Cazaubiel; Yazdan Yazdanpanah; Pierre Fontaine
Journal:  Diabetes Care       Date:  2008-01-09       Impact factor: 19.112

8.  Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial.

Authors:  José Luis Lázaro-Martínez; Javier Aragón-Sánchez; Esther García-Morales
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

9.  Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.

Authors:  Diane M Citron; Ellie J C Goldstein; C Vreni Merriam; Benjamin A Lipsky; Murray A Abramson
Journal:  J Clin Microbiol       Date:  2007-07-03       Impact factor: 5.948

10.  Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing.

Authors:  Scot E Dowd; Yan Sun; Patrick R Secor; Daniel D Rhoads; Benjamin M Wolcott; Garth A James; Randall D Wolcott
Journal:  BMC Microbiol       Date:  2008-03-06       Impact factor: 3.605

View more
  30 in total

1.  Discordant isolates in bone specimens from patients with recurrent foot osteomyelitis.

Authors:  Neal R Barshes; Cezarina Mindru; Barbara W Trautner; Maria C Rodriguez-Barradas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-05       Impact factor: 3.267

2.  [Pathogen analysis in patients with diabetic foot osteomyelitis using 16S rRNA high-throughput sequencing].

Authors:  Ping Hu; Meng-Chen Zou; Ying Cao; Yan-Ling Pan; Xiang-Rong Luo; Ya Jiang; Yao-Ming Xue; Fang Gao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

Review 3.  Biology and Biomarkers for Wound Healing.

Authors:  Linsey E Lindley; Olivera Stojadinovic; Irena Pastar; Marjana Tomic-Canic
Journal:  Plast Reconstr Surg       Date:  2016-09       Impact factor: 4.730

4.  Are We Misdiagnosing Diabetic Foot Osteomyelitis? Is the Gold Standard Gold?

Authors:  Lawrence A Lavery; P Andrew Crisologo; Javier La Fontaine; Kavitha Bhavan; Orhan K Oz; Kathryn E Davis
Journal:  J Foot Ankle Surg       Date:  2019-07       Impact factor: 1.286

Review 5.  Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery.

Authors:  Kenneth L Urish; James E Cassat
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 6.  Metagenomics to Identify Pathogens in Diabetic Foot Ulcers and the Potential Impact for Clinical Care.

Authors:  Brian M Schmidt; John Erb-Downward; Piyush Ranjan; Robert Dickson
Journal:  Curr Diab Rep       Date:  2021-06-21       Impact factor: 4.810

7.  Corynebacterium Species Rarely Cause Orthopedic Infections.

Authors:  Fabian Kalt; Bettina Schulthess; Reinhard Zbinden; Yvonne Achermann; Fabian Sidler; Sebastian Herren; Sandro F Fucentese; Patrick O Zingg; Martin Berli; Annelies S Zinkernagel
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

8.  Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disorders.

Authors:  Masahiro Abe; Muneyoshi Kimura; Hideyuki Maruyama; Tomohisa Watari; Sho Ogura; Shinsuke Takagi; Naoyuki Uchida; Yoshihito Otsuka; Shuichi Taniguchi; Hideki Araoka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-24       Impact factor: 3.267

9.  Staphylococcus aureus Triggers Induction of miR-15B-5P to Diminish DNA Repair and Deregulate Inflammatory Response in Diabetic Foot Ulcers.

Authors:  Horacio A Ramirez; Irena Pastar; Ivan Jozic; Olivera Stojadinovic; Rivka C Stone; Nkemcho Ojeh; Joel Gil; Stephen C Davis; Robert S Kirsner; Marjana Tomic-Canic
Journal:  J Invest Dermatol       Date:  2017-12-19       Impact factor: 8.551

10.  Single cell analyses reveal specific distribution of anti-bacterial molecule Perforin-2 in human skin and its modulation by wounding and Staphylococcus aureus infection.

Authors:  Natasa Strbo; Irena Pastar; Laura Romero; Vivien Chen; Milos Vujanac; Andrew P Sawaya; Ivan Jozic; Andrea D F Ferreira; Lulu L Wong; Cheyanne Head; Olivera Stojadinovic; Denisse Garcia; Katelyn O'Neill; Stefan Drakulich; Seth Taller; Robert S Kirsner; Marjana Tomic-Canic
Journal:  Exp Dermatol       Date:  2019-02-12       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.